the Power of Reversible Proteasome Inhibition Trademark Details
Word Mark | The Power of Reversible Proteasome Inhibition |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Millennium Pharmaceuticals, Inc. of Cambridge, MA
View all trademarks for Millennium Pharmaceuticals, Inc.Serial Number | 77478756 |
---|---|
Status Date | Monday, January 23, 2012 |
Filing Date | Monday, January 23, 2012 |
Attorney | Nancy C. DiConza |
Correspondent
NANCY C. DICONZA
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822
Case File Statements
Goods & Services | Prescription Pharmaceutical Preparations for Use in the Diagnosis or Treatment of Human Diseases and Disorders, Namely, Oncologic Diseases and Disorders, Excluding Analgesics |
---|---|
Goods & Services | Research Services, Namely, Research, Development, Validation, Testing, Data Analysis and Product Development Services in the Biomedical, Genomic, Pharmacogenomic, Diagnostic, Clinical Trial Design, and Biotechnology Fields; Research Consulting Services, Namely, Research, Development, Validation, Testing, Data Analysis, and Product Development Services for Others in the Biomedical, Genomic, Pharmaceutical, Pharmacogenomics, Diagnostic, Clinical Trial Design, and Biotechnology Fields; Consultation Services, Namely, Providing Consultation to Others via Global, National, and Local Computer Networks in the Fields of Life Sciences, Pharmacogenomics, Diagnostics, Clinical Trial Design and Biotechnology; Providing on-Line Computer Databases via Global, National, and Local Computer Networks in the Fields of Life Sciences, Pharmacogenomics, Diagnostics, Clinical Trial Design and Biotechnology |
Goods & Services | Medical Services and Medical Diagnostic Services, Namely, Diagnosing, Preventing, and Predicting Disease, Identifying Hereditary Risk Factors, Diagnostic Testing, Prognostic Testing, Gene and Protein Testing, Identifying Physiological Characteristics, Establishing Individual Preventative Programs, Establishing Disease Treatment Based on Gene and Protein Expression and/or Activity, Evaluating Clinical Trial Progress, Drug Monitoring and Computer Tracking of a Patient's Health Progress |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Friday, May 23, 2008 |
Primary Code | 005 |
International Class Codes |
040
|
---|---|
U.S. Class Codes | 100, 103, 106 |
Status | 6 — Active |
Status Date | Friday, May 23, 2008 |
Primary Code | 040 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Friday, May 23, 2008 |
Primary Code | 044 |
Trademark Timeline
-
May 20 2008Trademark application filed with USPTO
-
May 23 2008New Application Entered In Tram
-
Aug 15 2008Assigned To Examiner
-
Aug 16 2008Approved For Pub - Principal Register
-
Aug 26 2008Law Office Publication Review Completed
-
Aug 26 2008Assigned To Lie
-
Sep 10 2008Notice of Publication
-
Sep 30 2008Published For Opposition
-
Dec 23 2008Noa Mailed - Sou Required From Applicant
-
Jun 04 2009Extension 1 Granted
-
Jun 04 2009Extension 1 Filed
-
Jun 04 2009Teas Extension Received
-
Dec 04 2009Extension 2 Filed
-
Dec 04 2009Teas Extension Received
-
Jan 21 2010Extension 2 Granted
-
Jan 21 2010Case Assigned To Intent To Use Paralegal
-
Jun 02 2010Extension 3 Filed
-
Jun 02 2010Teas Extension Received
-
Jun 09 2010Extension 3 Granted
-
Jun 10 2010Notice of Approval of Extension Request Mailed
-
Nov 23 2010Extension 4 Filed
-
Nov 23 2010Teas Extension Received
-
Nov 26 2010Extension 4 Granted
-
Nov 27 2010Notice of Approval of Extension Request Mailed
-
Jun 10 2011Extension 5 Filed
-
Jun 10 2011Teas Extension Received
-
Jun 15 2011Extension 5 Granted
-
Jun 16 2011Notice of Approval of Extension Request Mailed
-
Jan 23 2012Abandonment Notice Mailed - No Use Statement Filed
-
Jan 23 2012Abandonment - No Use Statement Filed